CBIS CEU Opportunities with Rainbow Rehabililtation Centers

Earn One CBIS CEU at Rainbow's Community Education Learn Over Lunch

William Beaumont - Royal Oak and Detroit Receiving Hospitals are participating in ProTECT III, a study that aims to determine if progesterone (a hormone found naturally in our bodies) can decrease disability and death associated with TBI. Animal studies have demonstrated that progesterone may decrease the amount of brain damage that occurs after traumatic brain injury (TBI).

The double-blind study will evaluate patients who suffer from moderate to severe traumatic brain injuries, for consideration in the study. Enrolled patients will be randomly given either progesterone intravenously or a placebo, within four hours of the injury, and their outcomes post-injury will be assessed.

To learn more about ProTECT III, a traumatic brain injury study that may affect you or someone you know, attend Rainbow's Community Education session in March.

Date: March 11, 2010
Time: 12 p.m. - 2 p.m.
Location: Rainbow's Oakland Center
32715 Grand River Ave.
Farmington, MI 48336

A light lunch will be served. RSVP to Jenny Renaud at jenny.renaud@rainbowrehab.com.

Earn One CBIS CEU When You Read "Progesterone and Brain Injury"

Dr. Heidi Reyst, Rainbow Rehabilitation Centers' director of Clinical Administration, published "Progesterone and Brain Injury: The Work of Dr. Stein and Colleagues" for the Sept. 2009 issue of RainbowVisions Online. This article has been recently approved for one Certified Brain Injury Specialists CEU for reading the article and completing the associated form.

To receive the CEU, download and complete the attached form. Keep this form on file for your annual renewal.

• What is TBI?
• Brain Functions
• Glasgow Coma Scale
• Rainbow Literature
• RainbowVisions Magazine
• Article Downloads
• Conferences & Events
• Legislation Updates
• Subscriptions
• Links to Resources
• News and Information
• Press Room